1 year return (CAGR)
73.56%
Neoleukin Therapeutics Exchange (NASDAQ, USD)
NLTX
-
-40.74 (-72.96%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-60.64%
5 year return (CAGR)
-20.04%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
35.48M
Price/Sales
-
Ent value
24.60M
Price/Book
0.47
Div yield
-
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-13.40%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 14.57 |
| Daily high | 15.49 |
| Daily low | 13.75 |
| Daily Volume | 86K |
| 1y analyst estimate | 1.50 |
| Beta | 1.10 |
| EPS (TTM) | -3.55 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| NLTX | S&P500 | |
| Current price drop from All-time high | -96.59% | -0.60% |
| Highest price drop | -98.18% | -56.47% |
| Date of highest drop | 16 Nov 2022 | 9 Mar 2009 |
| Avg drop from high | -61.25% | -10.68% |
| Avg time to new high | 411 days | 12 days |
| Max time to new high | 2102 days | 1805 days |
News
No items found